Beta Adrenoceptor Agonists Market – Advanced Inhalers Support Respiratory Disease Management
The beta adrenoceptor agonists market is growing as respiratory conditions such as asthma and chronic obstructive pulmonary disease create sustained demand for bronchodilator therapies. The market was valued at USD 5.7 billion in 2024 and is projected to reach USD 8.2 billion by 2035, at a CAGR of 3.4%.wiseguyreports Asthma is the leading application segment and was valued at USD 2.45 billion...
0 Comments 0 Shares 109 Views 0 Reviews